Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart G P Koot

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|August 17, 2021
Identifying the Genetics Underlying Nonalcoholic Fatty Liver Disease: A Quest That is Far From OverBart G P Koot, Philip R Jansen
Journal of Pediatric Gastroenterology and Nutrition|October 25, 2017
Screening for NAFLD in Children: Do We Know the Optimal ALT Cut-off?Bart G P Koot, Marc A Benninga
Gastroenterology|February 8, 2018
A Rare Cause of Esophageal Stenosis in an InfantBart G P Koot, Wendela G Leeuwenburgh-Pronk, John Vlot
Journal of Pediatric Gastroenterology and Nutrition|November 24, 2020
Reply to "Rapid Infliximab Infusions in Paediatric Inflammatory Bowel Disease Patients, a Single Hospital Experience"Elsa A van Wassenaer, Marc A Benninga, Bart G P Koot
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 15, 2025
Reply to Letter to the Editor: 'ALT and Novel Fibrosis Scores for Risk Stratification of Pediatric MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
European Journal of Pediatrics|August 10, 2004
Congenital analbuminaemia: biochemical and clinical implications. A case report and literature reviewBart G P Koot, Roderick Houwen, Dirk-Jan Pot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2026
Reply to Letter to the Editor: 'Unaddressed Limitations of ALT as a Screening Tool for Paediatric Advanced MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
European Journal of Pediatrics|November 2, 2020
Fool me once… treatment exposure to achieve remission in pediatric IBDJohan E Van Limbergen, Bart G P Koot, J Peter de Winter
European Journal of Pediatrics|November 19, 2024
Pediatric MASLD: current understanding and practical approachAnne-Sophie R Stroes, Miriam Vos, Marc A Benninga, et al.
Journal of Hepatology|December 15, 2015
A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertensionBart G P Koot, Marielle Alders, Joanne Verheij, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Pediatric Gastroenterology and Nutrition|August 17, 2021
Identifying the Genetics Underlying Nonalcoholic Fatty Liver Disease: A Quest That is Far From OverBart G P Koot, Philip R Jansen
Journal of Pediatric Gastroenterology and Nutrition|October 25, 2017
Screening for NAFLD in Children: Do We Know the Optimal ALT Cut-off?Bart G P Koot, Marc A Benninga
Gastroenterology|February 8, 2018
A Rare Cause of Esophageal Stenosis in an InfantBart G P Koot, Wendela G Leeuwenburgh-Pronk, John Vlot
Journal of Pediatric Gastroenterology and Nutrition|November 24, 2020
Reply to "Rapid Infliximab Infusions in Paediatric Inflammatory Bowel Disease Patients, a Single Hospital Experience"Elsa A van Wassenaer, Marc A Benninga, Bart G P Koot
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 15, 2025
Reply to Letter to the Editor: 'ALT and Novel Fibrosis Scores for Risk Stratification of Pediatric MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
European Journal of Pediatrics|August 10, 2004
Congenital analbuminaemia: biochemical and clinical implications. A case report and literature reviewBart G P Koot, Roderick Houwen, Dirk-Jan Pot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2026
Reply to Letter to the Editor: 'Unaddressed Limitations of ALT as a Screening Tool for Paediatric Advanced MASLD'Anne-Sophie R Stroes, Marc A Benninga, Bart G P Koot
European Journal of Pediatrics|November 2, 2020
Fool me once… treatment exposure to achieve remission in pediatric IBDJohan E Van Limbergen, Bart G P Koot, J Peter de Winter
European Journal of Pediatrics|November 19, 2024
Pediatric MASLD: current understanding and practical approachAnne-Sophie R Stroes, Miriam Vos, Marc A Benninga, et al.
Journal of Hepatology|December 15, 2015
A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertensionBart G P Koot, Marielle Alders, Joanne Verheij, et al.
Pageof 7